Sequent Scientific Revenue vs. Total Debt
SEQUENT Stock | 203.32 4.05 2.03% |
Total Revenue | First Reported 2012-06-30 | Previous Quarter 3.9 B | Current Value 3.7 B | Quarterly Volatility 1 B |
For Sequent Scientific profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sequent Scientific to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sequent Scientific Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sequent Scientific's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sequent Scientific Limited over time as well as its relative position and ranking within its peers.
Sequent |
Sequent Scientific Total Debt vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sequent Scientific's current stock value. Our valuation model uses many indicators to compare Sequent Scientific value to that of its competitors to determine the firm's financial worth. Sequent Scientific Limited is currently regarded number one company in revenue category among its peers. It also is currently regarded number one company in total debt category among its peers making up about 0.36 of Total Debt per Revenue. The ratio of Revenue to Total Debt for Sequent Scientific Limited is roughly 2.81 . At this time, Sequent Scientific's Total Revenue is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sequent Scientific's earnings, one of the primary drivers of an investment's value.Sequent Revenue vs. Competition
Sequent Scientific Limited is currently regarded number one company in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 129.9 Billion. Sequent Scientific retains roughly 13.7 Billion in revenue claiming about 11% of equities under Health Care industry.
Sequent Total Debt vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Sequent Scientific |
| = | 13.7 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Sequent Scientific |
| = | 4.88 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Sequent Total Debt vs Competition
Sequent Scientific Limited is currently regarded number one company in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 22.27 Billion. Sequent Scientific totals roughly 4.88 Billion in total debt claiming about 22% of equities under Health Care industry.
Sequent Scientific Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sequent Scientific, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sequent Scientific will eventually generate negative long term returns. The profitability progress is the general direction of Sequent Scientific's change in net profit over the period of time. It can combine multiple indicators of Sequent Scientific, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Accumulated Other Comprehensive Income | -3.9 B | -3.7 B | |
Operating Income | 76.9 M | 73.1 M | |
Income Before Tax | -546.5 M | -519.1 M | |
Total Other Income Expense Net | -623.4 M | -654.5 M | |
Net Loss | -358.7 M | -340.8 M | |
Income Tax Expense | -250.3 M | -237.8 M | |
Net Loss | -296.1 M | -281.3 M | |
Net Loss | -1.4 B | -1.3 B | |
Interest Income | 590.1 M | 337.2 M | |
Net Interest Income | -480.9 M | -504.9 M | |
Change To Netincome | 1.5 B | 1.6 B |
Sequent Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sequent Scientific. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sequent Scientific position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sequent Scientific's important profitability drivers and their relationship over time.
Use Sequent Scientific in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sequent Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sequent Scientific will appreciate offsetting losses from the drop in the long position's value.Sequent Scientific Pair Trading
Sequent Scientific Limited Pair Trading Analysis
The ability to find closely correlated positions to Sequent Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sequent Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sequent Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sequent Scientific Limited to buy it.
The correlation of Sequent Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sequent Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sequent Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sequent Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sequent Scientific position
In addition to having Sequent Scientific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Advertising Thematic Idea Now
Advertising
Companies specializing in advertising, marketing and advertising services. The Advertising theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Advertising Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Sequent Stock Analysis
When running Sequent Scientific's price analysis, check to measure Sequent Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sequent Scientific is operating at the current time. Most of Sequent Scientific's value examination focuses on studying past and present price action to predict the probability of Sequent Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sequent Scientific's price. Additionally, you may evaluate how the addition of Sequent Scientific to your portfolios can decrease your overall portfolio volatility.